» Articles » PMID: 26675376

Analysis of Risk and Predictors of Brain Radiation Necrosis After Radiosurgery

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Dec 18
PMID 26675376
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we examined the factors contributing to brain radiation necrosis and its predictors of patients treated with Cyberknife radiosurgery. A total of 94 patients with primary or metastatic brain tumours having been treated with Cyberknife radiotherapy from Sep. 2006 to Oct. 2011 were collected and retrospectively analyzed. Skull based tracking was used to deliver radiation to 104 target sites. and the prescribed radiation doses ranged from 1200 to 4500 cGy in 1 to 8 fractions with a 60% to 87% isodose line. Radiation necrosis was confirmed by imaging or pathological examination. Associations between cerebral radiation necrosis and factors including diabetes, cardio-cerebrovascular disease, target volume, isodose line, prescribed dosage, number of fractions, combination with whole brain radiation and biologically equivalent dose (BED) were determined by logistic regression. ROC curves were created to measure the predictive accuracy of influence factors and identify the threshold for brain radiation necrosis. Our results showed that radiation necrosis occurred in 12 targets (11.54%). Brain radiation necrosis was associated by BED, combination with whole brain radiotherapy, and fractions (areas under the ROC curves = 0.892±0.0335, 0.650±0.0717, and 0.712±0.0637 respectively). Among these factors, only BED had the capability to predict brain radiation necrosis, and the threshold dose was 7410 cGy. In conclusion, BED is the most effective predictor of brain radiation necrosis, with a dose of 7410 cGy being identified as the threshold.

Citing Articles

Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer.

McGranahan T, Bonm A, Specht J, Venur V, Lo S Cancers (Basel). 2022; 14(20).

PMID: 36291922 PMC: 9601150. DOI: 10.3390/cancers14205136.


An Analysis of Risk Factors for Radiation Necrosis Following Cranial Radiation.

Nissen C, Ying J, Newkirk M, Narayanasamy G, Lewis G, Xia F Cureus. 2022; 14(9):e29268.

PMID: 36133504 PMC: 9482441. DOI: 10.7759/cureus.29268.


[Expert Consensus on the Treatment of Antiangiogenic Agents for Radiation Brain Necrosis].

Chen Y, Wang X, Sun B, Meng M, Wang E, Yuan Z Zhongguo Fei Ai Za Zhi. 2022; 25(5):291-294.

PMID: 35570144 PMC: 9127755. DOI: 10.3779/j.issn.1009-3419.2022.101.18.


Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.

Vaios E, Batich K, Buckley A, Dunn-Pirio A, Patel M, Kirkpatrick J Oncotarget. 2022; 13:576-582.

PMID: 35359747 PMC: 8963718. DOI: 10.18632/oncotarget.28222.


Management of brain metastases in elderly patients with lung cancer.

Socha J, Rychter A, Kepka L J Thorac Dis. 2021; 13(5):3295-3307.

PMID: 34164222 PMC: 8182516. DOI: 10.21037/jtd-2019-rbmlc-05.


References
1.
Coderre J, Morris G, Micca P, Hopewell J, Verhagen I, Kleiboer B . Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res. 2006; 166(3):495-503. DOI: 10.1667/RR3597.1. View

2.
Olson A, Wegner R, Rwigema J, Heron D, Burton S, Mintz A . Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgery. J Cancer Res Ther. 2012; 8(3):411-6. DOI: 10.4103/0973-1482.103522. View

3.
Soussain C, Ricard D, Fike J, Mazeron J, Psimaras D, Delattre J . CNS complications of radiotherapy and chemotherapy. Lancet. 2009; 374(9701):1639-51. DOI: 10.1016/S0140-6736(09)61299-X. View

4.
Reddy K, Westerly D, Chen C . MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas. J Med Imaging Radiat Oncol. 2013; 57(3):349-55. DOI: 10.1111/j.1754-9485.2012.02472.x. View

5.
Nordal R, Nagy A, Pintilie M, Wong C . Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res. 2004; 10(10):3342-53. DOI: 10.1158/1078-0432.CCR-03-0426. View